|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,403.50 JPY | -0.21% |
|
-1.09% | -9.01% |
| Mar. 11 | Cellavision launches bone marrow application in EMEA | FW |
| Mar. 05 | Sysmex Corporation authorizes a Buyback Plan. | CI |
| Capitalization | 875B 5.48B 4.79B 4.33B 4.14B 7.53B 507B 7.83B 51.7B 20.49B 242B 20.56B 20.13B | P/E ratio 2026 * |
19.2x | P/E ratio 2027 * | 17x |
|---|---|---|---|---|---|
| Enterprise value | 836B 5.24B 4.58B 4.14B 3.96B 7.2B 485B 7.48B 49.42B 19.59B 231B 19.66B 19.24B | EV / Sales 2026 * |
1.66x | EV / Sales 2027 * | 1.53x |
| Free-Float |
72.27% | Yield 2026 * |
2.64% | Yield 2027 * | 2.75% |
| 1 day | -0.21% | ||
| 1 week | -1.09% | ||
| Current month | -4.65% | ||
| 1 month | -11.40% | ||
| 3 months | -4.10% | ||
| 6 months | -25.78% | ||
| Current year | -9.01% |
| 1 week | 1,399.5 |  | 1,555.5 |
| 1 month | 1,268 | | 1,568.5 |
| Current year | 1,268 | | 1,609.5 |
| 1 year | 1,268 | | 2,934 |
| 3 years | 1,268 | | 3,480 |
| 5 years | 1,268 | | 5,241.67 |
| 10 years | 1,268 | | 5,241.67 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hisashi Ietsugu
CEO | Chief Executive Officer | 76 | 2018-03-31 |
Kaoru Asano
PSD | President | 67 | 2023-03-31 |
Tomokazu Yoshida
CTO | Chief Tech/Sci/R&D Officer | 61 | 2023-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Hisashi Ietsugu
CHM | Chairman | 76 | 2013-03-31 |
Kaoru Asano
BRD | Director/Board Member | 67 | 2014-05-31 |
Kenji Tachibana
BRD | Director/Board Member | 68 | 2014-05-31 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +3.66% | 1.35% | 47 M€ | |
| +1.82% | 0.65% | 12 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.21% | -1.09% | -48.13% | -50.97% | 5.5B | |
| -0.10% | -2.71% | -17.08% | +11.42% | 188B | |
| -0.27% | -6.31% | -4.78% | +13.58% | 112B | |
| -0.77% | -2.60% | +37.78% | +133.92% | 68.6B | |
| +0.22% | -1.33% | +61.47% | +94.91% | 58.6B | |
| -0.17% | -6.23% | -28.80% | -30.63% | 45.45B | |
| +0.95% | -5.41% | - | - | 33.33B | |
| -1.56% | -5.67% | -6.19% | -41.95% | 25.12B | |
| +1.05% | -10.04% | -4.40% | +20.88% | 20.83B | |
| +1.32% | +4.86% | -23.90% | +15.47% | 18.94B | |
| Average | +0.35% | -4.09% | -3.78% | +18.52% | 57.65B | |
| Weighted average by Cap. | +0.55% | -3.90% | +0.32% | +30.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 504B 3.16B 2.76B 2.49B 2.38B 4.34B 292B 4.51B 29.78B 11.8B 139B 11.84B 11.59B | 544B 3.41B 2.98B 2.69B 2.57B 4.68B 315B 4.87B 32.14B 12.73B 151B 12.78B 12.51B |
| Net income | 45.68B 286M 250M 226M 216M 393M 26.47B 409M 2.7B 1.07B 12.65B 1.07B 1.05B | 51.42B 322M 282M 254M 243M 443M 29.8B 460M 3.04B 1.2B 14.24B 1.21B 1.18B |
| Net Debt | -38.53B -241M -211M -191M -182M -332M -22.33B -345M -2.28B -903M -10.67B -906M -887M | -42.7B -268M -234M -211M -202M -368M -24.75B -382M -2.52B -1B -11.82B -1B -983M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-03-13 | 1,403.50 ¥ | -0.21% | 5,222,400 |
| 26-03-12 | 1,406.50 ¥ | -3.13% | 4,865,600 |
| 26-03-11 | 1,452.00 ¥ | -3.87% | 6,359,300 |
| 26-03-10 | 1,510.50 ¥ | -2.89% | 5,392,200 |
| 26-03-09 | 1,555.50 ¥ | +0.94% | 8,662,400 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 6869 Stock
Select your edition
All financial news and data tailored to specific country editions
